-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/trauma-child-interventions_disposition-comments.pdf
February 11, 2013 - need for caution due to potential adverse reactions) in treating
post-traumatic stress and related symptoms … We did,
however, include these outcomes for
studies that also looked at traumatic stress
symptoms … TEP #5 Introduction The report focuses too heavily on PTSD-type symptoms as characterizing
traumatic … We did,
however, include these outcomes for
studies that also looked at traumatic stress
symptoms … Not symptoms or
diagnosis.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/asthma-treatment_disposition-comments.pdf
September 10, 2012 - In both instances, all patients in the experimental group
were effectively cured of all symptoms and … the patients all
suffered from advanced asthmatic symptoms and as many as 20
other illnesses. … My asthma symptoms started abating in two weeks, and, while
not completely "cured", I have had no attacks … Clinical results were mostly equivalent:
significant decreases of >50% in panic symptoms, clinically … significant decreases in asthma symptoms, improvement in
asthma quality of life, and maintenance of
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-surv-report-1-noninvasive-nonpharma_0.xlsx
January 01, 2021 - vs. 61 vs. 65 years
Female: 29% vs. 35% vs. 28%
Race:
- Caucasian: 41% vs. 33% vs. 37%
Duration of symptoms … NR
6 months
Proportion of patients with high levels of symptoms:
- HAD Depression score >10: 8 (44.4% … B
Age: 66 vs. 66 years
Female: NR
Race: NR
Duration of symptoms: NR
Pain etiology/type or diagnostic … C
Age: 39 vs. 36 vs. 37 years
Female: 20% vs. 24% vs. 19%
Race/Ethnicity: NR
Duration of Symptoms: 6 … B
Age: 38 vs. 33 years
Female: 49% vs. 51%
Race/Ethnicity: NR
Duration of Symptoms: 12 vs. 18 months
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-surv-report-2-noninvasive-nonpharma.xlsx
January 01, 2021 - vs. 61 vs. 65 years
Female: 29% vs. 35% vs. 28%
Race:
- Caucasian: 41% vs. 33% vs. 37%
Duration of symptoms … NR
6 months
Proportion of patients with high levels of symptoms:
- HAD Depression score >10: 8 (44.4% … B
Age: 66 vs. 66 years
Female: NR
Race: NR
Duration of symptoms: NR
Pain etiology/type or diagnostic … C
Age: 39 vs. 36 vs. 37 years
Female: 20% vs. 24% vs. 19%
Race/Ethnicity: NR
Duration of Symptoms: 6 … B
Age: 38 vs. 33 years
Female: 49% vs. 51%
Race/Ethnicity: NR
Duration of Symptoms: 12 vs. 18 months
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/autism_executive.pdf
April 01, 2011 - Outcomes included changes in core ASD
symptoms and in commonly associated symptoms
(Figure A). … , a
few medications show benefit for repetitive behaviors or
associated symptoms. … Individual therapies are
developed and tested to ameliorate specific symptoms
or groups of symptoms, … Change in
autism core symptoms with early intervention: predictors and
outcomes. … Change in
autism core symptoms with intervention.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/asthma-treatment_research-protocol.pdf
February 10, 2010 - characteristics varies among susceptible individuals leading to differences in disease progression
and symptoms … Symptoms can include shortness of breath, cough, wheezing, and chest
pain or tightness.1 When poorly … achieve and maintain control of persistent asthma and quick-relief medications used to treat
acute symptoms … (e.g., cough, wheezing, dyspnea, nocturnal symptoms)
• Health-related quality of life (general and/ … (e.g., cough, wheezing,
dyspnea, nocturnal symptoms)
Health-related quality of life
(general
-
effectivehealthcare.ahrq.gov/sites/default/files/dementia-horizon-scan-high-impact-1412.pdf
February 01, 2015 - Most available
dementia and AD interventions are approved to manage symptoms; however, promising research … due to the difficulties associated with specifically quantifying improvements in disease state
and symptoms … Researchers hypothesize that reduced serotonin levels are a primary
cause of agitation symptoms in … trial indicated that citalopram was more
effective than placebo in improving patients’ agitation symptoms … Food and Drug Administration (FDA) treat only AD symptoms; they are not
disease-modifying.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/antipsychotics-children-future_research.pdf
February 01, 2012 - NA NA NA Moderate SOE NA
Tic severity NA NA NA NA Moderate
SOE
aBehavioral symptoms defined by … These
side effects include extra-pyramidal symptoms (EPS). … However, SGAs did not differ from placebo for depression symptoms in this
group (low SOE). … ; HRQL=health related quality of life; KQ=key question; PANSS=Positive and Negative Symptoms Scale. … specific to disorders (e.g., positive symptoms of
schizophrenia) or for the disorders themselves.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/palliative-care-research-amended-protocol.pdf
November 21, 2019 - worsening of illness such as worsening functional
status, or frequent phone calls indicating uncontrolled symptoms … or symptom burden (includes multidimensional symptom tools
and key symptoms of pain, dyspnea, fatigue … or
psychological well-being
Caregiver burden, caregiver impact or caregiver strain
Patient symptoms … or symptom burden (includes
multidimensional symptom tools and key symptoms of
Studies that do not … disciplines are involved, schedules of visits and assessments, and any standard elements such as
symptoms
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/wireless-motility-capsule_executive.pdf
May 01, 2013 - Gastroparesis
Definition and Prevalence
Gastroparesis is a condition in which
patients experience symptoms … of delayed
gastric emptying in the absence of an
actual physical blockage.1 The most
common symptoms … Evaluation of Possible Gastroparesis
A standard assessment for patients with typical symptoms
(e.g. … Antroduodenal manometry
may help differentiate myopathic and neuropathic
etiologies of symptoms. … Clinicians should ask about warning signs
such as new onset of symptoms, obstructive symptoms,
rectal
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/appendicitis_executive.pdf
December 01, 2015 - Clinical symptoms and signs suggestive
of appendicitis include a history of central
abdominal pain … Clinical symptoms and signs can be
evaluated relatively easily and inexpensively. … results for selected
clinical symptoms and signs. … Symptoms and signs had
limited test performance when used in isolation. … They
may, for example, have more severe symptoms or have
atypical findings on other tests.
-
effectivehealthcare.ahrq.gov/sites/default/files/asthma-self-mgmt-summary.pdf
April 01, 2020 - Frequently reported outcomes were asthma
control, asthma knowledge, symptoms, quality of
life,
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-235-pharma-nonpharma-ptsd-update-summary.pdf
November 01, 2020 - People with
PTSD have symptoms such as flashbacks, avoidance of trauma-related stimuli, negative
beliefs … These symptoms reduce
quality of life and functioning. … diagnosis (i.e., no longer meeting
criteria for PTSD) or clinically meaningful response/remission of symptoms … the included studies
reported loss of PTSD diagnosis or clinically meaningful response/remission of
symptoms
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/version-3-immunity-after-COVID-19.pdf
December 31, 2022 - reinfection vary by factors
such as initial antibody levels, patient
characteristics, presence of symptoms … Seropositivity at baseline also reduced the incidence of symptoms associated with COVID-19,
such as … or mild symptoms: adjusted HR 6.6 (95%
CI, 2.6-17), p<0.001
Masia, 2021* 132 Median 6 days
and … (persons with 0-2 symptoms
had higher risk of lacking antibodies
compared with persons with 6-9 symptoms … compared to no symptoms:
Adjusted OR 0.23, 95% CI 0.19-0.29, p<0.001
and adjusted OR classic symptoms
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/uterine-fibroids_research-protocol.pdf
March 01, 2016 - ages of 15 and 50 have uterine
fibroids.1-4 More than 15 million of them will experience associated symptoms … or health
concerns.5,6 A disproportionate number of black women are among those with symptoms
in part … well as concerns about influence
on fertility and pregnancy outcomes.9
Fibroids are prevalent and symptoms … Food and Drug
Administration (FDA) for treatment of fibroid symptoms, though several medications are … symptoms.
-
effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/white-paper-library-afib.pdf
November 15, 2018 - Symptoms or signs must persist ≥24 hours, or if documented by CT, MRI or autopsy,
the duration of symptoms … Symptoms or
signs must persist ≥24 hours, or if documented by CT, MRI or autopsy, the duration of … symptoms/signs may be less than 24 hours. … Cardiac death with symptoms suggestive of myocardial ischemia and presumed new
ischemic ECG changes … In addition, either (i) symptoms suggestive of myocardial ischemia
or (ii) new ischemic ECG changes
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/gout_research-protocol-2014.pdf
January 01, 2014 - A question of interest is
whether any combination of clinical signs and symptoms and laboratory tests … What is the accuracy of clinical signs and symptoms and other diagnostic
tests (such as serum uric … How does the diagnostic accuracy of clinical signs and symptoms and other tests
vary by affected joint … #
PICOTs
• Population(s) (KQ1 and 2):
o Adults (18 years and over) presenting with symptoms (e.g … Tests to be included are clinical examination for physical signs, symptoms,
and history; ultrasonography
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0107_05-19-2009.pdf
January 01, 2009 - Outcome(s): Prevention of the onset of asthma and additional sensitivities; significant
reductions in symptoms … Patients benefit by improved allergic symptoms that do not respond to standard
pharmacotherapy or allergen
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/autism_research-protocol.pdf
December 09, 2009 - conditions such as seizure disorders, hyperactivity, and anxiety.4
The manifestation and severity of symptoms … account a
child’s developmental context; however treatment is frequently complicated by emergent
symptoms … KQ1b: What are the effects on commonly associated symptoms (e.g. motor, sensory,
medical, mood/anxiety … KQ1c: What are the longer-term effects (>6 mos) on core symptoms (e.g. social deficits,
communication … KQ1d: What are the longer-term effects (>6 mos) on commonly associated symptoms (e.g.
-
effectivehealthcare.ahrq.gov/sites/default/files/therapies-for-autism-spectrum-disorder-2-9-2010.pdf
January 01, 2010 - conditions such as seizure disorders, hyperactivity, and anxiety.4
The manifestation and severity of symptoms … account a
child’s developmental context; however treatment is frequently complicated by emergent
symptoms … KQ1b: What are the effects on commonly associated symptoms (e.g. motor, sensory,
medical, mood/anxiety … KQ1c: What are the longer-term effects (>6 mos) on core symptoms (e.g. social deficits,
communication … KQ1d: What are the longer-term effects (>6 mos) on commonly associated symptoms (e.g.